
28
Annual Report 2022Highlights About Pexip Corporate Governance Financials
its business, including intellectual property rights
disputes. The value of intellectual property rights
is of high importance for Pexip, as it operates in a
highly competitive commercial environment where
the strength of the intellectual property rights may
be an important feature that distinguishes Pexip
from its competitors. It is therefore important for
Pexip to ensure the value and commercial use of
its intellectual property rights. There can be no
assurance that third parties have not or may not
infringed intellectual property rights owned by
Pexip, who may have to challenge such parties’
rights to continue to use or sell certain products
and/or may seek damages from such parties.
Moreover, there can be no assurance that Pexip
may not infringe or be alleged to have infringed
intellectual property rights owned by third parties
who may challenge Pexip’s right to continue to use
or sell certain products and/or may seek damages
from Pexip. Any infringement or other intellectual
property claims made by or against Pexip could be
time-consuming, result in costly litigation, cause
product delays, divert its management from their
regular responsibilities or require Pexip to enter into
royalty or licensing agreements.
Laws Regulations and Compliance Risk
Mitigation
Pexip monitors the development of laws and
regulations in the markets it operates in, especially
within the data privacy area which has seen
significant development in recent years. Industry
standard insurance policies are also in place.
Financial and Market Risk
Pexip’s profitability, operating results and working
capital may fluctuate significantly. Operating in a
global, fast-changing market, Pexip’s profitability,
results of operations and working capital may
fluctuate significantly on a quarterly and annual
basis. In 2023 the company is targeting an EBITDA
of NOK 100-150 million. The subscription-based
revenues may also fluctuate significantly, both in
the short-term and long-term. Working capital
may also fluctuate significantly on a quarterly and
on an annual basis, which could have a material
adverse effect on Pexip’s business and financial
performance. This may be caused by factors beyond
Pexip’s control, such as variations in the timing of
orders and deliveries, new product introductions by
Pexip and its competitors, variations in spending
budgets of customers, shifts in market and industry
emphasis and end user demands, and general
economic conditions and economic conditions.
Pexip is exposed to foreign currency exchange
risk. Because a significant part of Pexip’s business
is conducted in currencies other than its functional
reporting currency (NOK, as defined below)
and Pexip has its majority of ARR in contracts
denominated in USD, Pexip will be exposed to
volatility associated with foreign currency exchange
rates. Exchange rate fluctuations may affect Pexip’s
financial results through translation of the profit
and loss accounts and balance sheets of foreign
subsidiaries into NOK. Currency risks may also arise
when Group companies enter into transactions
that are denominated in currencies other than their
functional currency. Pexip itself is also invoiced
in other currencies than its functional currency,
thus resulting in currency exposure from both a
customer and supplier position. Currency exposure
is the result of purchases of goods and services in
other currencies than Pexip’s functional currency
(transaction exposure) and of the conversion of
the balance sheets and income statements in
foreign currencies into NOK (translation exposure).
Such translation exposure does not give rise to an
immediate cash effect. Pexip does not use financial
instruments to hedge its exposure to foreign
exchange rate risks, and there is no guarantee
that Pexip’s financial results will not be adversely
affected by currency exchange rate fluctuations
or that any efforts by Pexip to engage in currency
hedging activities will be effective.
Pexip is exposed to risk relating to impairment
of intangible assets, including goodwill. The
company’s audited consolidated financial statement
for the year ended 31 December 2022 was prepared
in accordance with the International Financial
Reporting Standards (IFRS), as adopted by the
European Union. As of 31 December 2022, Pexip’s
non-current assets amounted to approximately
NOK 1,408 million which constituted 67% of Pexip’s
total assets, most of which are intangible assets
including NOK 663 million in goodwill. Goodwill
acquired in a business combination is not amortized
pursuant to IFRS, but is tested for impairment
annually, or more often, if an event or circumstance
indicates that an impairment loss may have been
incurred. The key assumption affecting the present
Statement from the BoD